Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
By A. Forastiere, H. Goepfert, M. Maor, T. Pajak, R. Weber, W. Morrison, B. Glisson, A. Trotti, J. Ridge, C. Chao and 5 more. New England Journal of Medicine, 2003
2,970 citations recorded by the source corpus.
Subfields: Otorhinolaryngology, Physiology, Surgery
View Paper: https://www.semanticscholar.org/paper/f92f53104e4d86670147a6d4b930bc6c415a5a48
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Otorhinolaryngology
In Surgery
Citations in the corpus
- An update on larynx cancer (2017, background): “We note that patients with bulky T4 masses, defined as a tumor penetrating through the thyroid cartilage or invading 1 cm into the base of the tongue, were excluded from that study, and total laryngectomy remains the standard of care for these patients.(41,67) Despite the sound support for larynx pr”
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. (2016, background): “The long-term follow-up report revealed a significant improvement in rates of larynx preservation and local control at 5 and 10 years with concomitant cisplatin and radiation compared with induction therapy or radiation alone and no significant difference in overall survival among the 3 treatment gr”
- Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. (2013, background): “One of these trials, Radiation Therapy Oncology Group (RTOG) 9111, for resectable stage III and IV cancer of the larynx, led to a change in the treatment paradigm for larynx preservation from induction cisplatin and fluorouracil (PF) followed, in good responders, by radiotherapy (RT) to concomitant ”